ArticleBMC urology2025
Double-J stenting during TURBT increases risk of metachronous upper tract urothelial carcinoma.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- When double-J stents become a risk: bilateral distal ureteric urothelial carcinoma following ureteric instrumentation: a case report.BMC urology · 2026Article
- Dual Challenges: Addressing Post-Traumatic Retroperitoneal Urinoma in the Context of Pyeloureteral Duplication.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveThe potential impact of double-J (DJ) stenting during transurethral resection of bladder tumor (TURBT) on the occurrence of metachronous upper urinary tract urothelial carcinoma (UTUC) remains a subject of debate. This study investigates the effect of DJ stenting during TURBT for bladder cancer (BC) on the incidence of metachronous UTUC.
methodsWe retrospectively analyzed the data from patients who underwent TURBT at our institution between September 2013 and September 2023. Patients were grouped based on whether DJ stents were placed during TURBT. The outcome was the occurrence of metachronous UTUC, defined by UTUC occurring 3 months after TURBT. We define UTUC in DJ group occurring 3 months to 24 months post-TURBT as stent-related metachronous UTUC. Propensity scores adjustment was computed to control the confounding factors (p < 0.05). Kaplan-Meier analyses estimated metachronous UTUC recurrence-free survival (RFS) before and after propensity scores adjustment. Cox regression analyses were used to evaluate the data. Subgroup analyses and interaction tests for all categorical variables were conducted.
resultsA total of 570 patients were included in this study. We identified 19 (3.33%) patients were metachronous UTUC. Among patients with metachronous UTUC, 7 patients received DJ stents, while 12 patients did not receive DJ stents. Kaplan-Meier analysis showed poorer recurrence-free survival in the DJ group during the first two years postoperatively (unadjusted p < 0.001 VS. adjusted p = 0.006) and throughout the entire follow-up period (unadjusted p < 0.001 VS. adjusted p < 0.001). Cox multivariable regression analysis revealed that the placement of DJ stent was an independent risk factor for metachronous UTUC-free survival rates within the first two years postoperatively ( p = 0.003) or during the overall follow-up period ( p < 0.001).
conclusionsPatients who underwent DJ stenting during TURBT for BC exhibited an increased risk of developing metachronous UTUC, suggesting a potential association that warrants further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.